Posts

Montelukast/Singulair now has a "black box" warning by the FDA due to neuropsychiatric events

Identification of asthmatic patients who respond to Singulair (montelukast) is important as response is variable

Low-dose fluticasone is less expensive and more effective than montelukast in children with asthma

Intravenous montelukast not helpful in children with acute asthma